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Abstract
The mechanisms used by murine polyomavirus for intracellular migration are yet to be clarified. In this work we selectively
depolymerized microtubules or actin fibers and then studied the progression of polyomavirus infection in cultured cells. Our results
demonstrate that microtubule depolymerization prevents polyomavirus migration toward the nucleus and from the nucleus to the cell
surface, being also involved in viral release, while disruption of the actin microfilaments appears to have no detrimental effect on the virus
ability to reach the nucleus. The ultrastructural observation of polyomavirus nonenveloped particles interacting with the free end and the
lateral sides of microtubules together with the coimmunoprecipitation of tubulin and viral VP-1 further supports the idea that polyomavirus
intracellular migration seems to be mediated by the interaction of polyomavirus major capsid protein VP-1 with tubulin.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Polyomavirus; Microtubules; Tubulin; Actin; Cytoskeleton
Introduction
Murine polyomavirus is a small, nonenveloped double-
stranded DNA virus that can infect permissive mouse cells
or transform nonpermissive rat cells through a complex
interaction with different cellular regulators (Alberts et al.,
1994; Courtneidge and Smith, 1983; Cullere et al., 1998;
Dahl et al., 1998; Dawe et al., 1987; Dilworth et al., 1994;
Freund et al., 1992; Glover et al., 1999). After inoculation
into newborn mice, some strains of polyomavirus induce
epithelial and mesenchymal tumors (Dawe et al., 1987;
Freund et al., 1987; Sanjuan et al., 2001) and it has been
proposed that the tumorigenic potential of the different viral
strains is directly related to its ability to disseminate in the
mouse (Dubensky et al., 1991). Thus, the mechanisms in-
volved in polyomavirus replication and cell-to-cell spread
are critical for understanding the bases of polyomavirus
pathogenesis.
The murine polyomavirus receptor has been partially
characterized but is still unknown (Bauer et al., 1999; Chen
and Benjamin, 1997; Sanjuan et al., 1992; Stehle et al.,
1994). The entrance of polyomavirus into cells is also
poorly understood. It has recently been published that
caveolae are involved in polyomavirus endocytosis (Rich-
terova et al., 2001) similarly to the mechanism used by the
closely related simian virus SV-40 (Pelkmans et al., 2001).
However, other reports proposed a different mechanism for
polyomavirus entrance into the cell (Gilbert and Benjamin,
2000).
Viral intracellular migration and budding have been ex-
tensively studied in enveloped viruses (Boulan and Sabatini,
1978; Sodeik, 2000; Sodeik et al., 1997) but much less is
known about intracellular migration of nonenveloped par-
ticles such as polyomavirus. Several reports showed that the
cytoskeleton plays an important role in the intracellular
traffic of some viruses (Cudmore et al., 1995; Sasaki et al.,
1995; Sodeik, 2000; Sodeik et al., 1997; Ward and Moss,
2001). In the case of polyomavirus, there are conflicting
reports about the role played by actin fibers in viral intra-
cellular traffic (Krauzewicz et al., 2000; Richterova et al.,
2001). Envelope-coated polyomavirus particles have been
described to be associated with microfilaments bundles, but
the significance of this finding is still unclear (Richterova et
al., 2001). In any case, the reports that focused on murine
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polyomavirus were limited to the early steps of viral en-
trance and transportation, usually not beyond 3 h postinfec-
tion (p.i.) (Pelkmans et al., 2001; Richterova et al., 2001).
This article presents a straightforward study on the role
of the cytoskeleton in murine polyomavirus traffic. The
effect that selective depolymerization of microtubules or
actin fibers had on viral infection was studied focusing
especially on the events at 48 to 96 h p.i. Viral release was
also studied. Immunocytochemistry, transmission electron
microscopy, and immunoprecipitation were used in polar-
ized and nonpolarized murine cells. The present results
demonstrate that microtubules are essential for the progres-
sion of polyomavirus infection toward the nucleous and for
the exit of progeny virus. Moreover, it reveals that “naked”
polyomavirus particles are attached to the free end and the
lateral sides of microtubules in a different way than reported
in other studies. The coimmunoprecipitation of polyomavi-
rus major capsid protein VP-1 with tubulin further supports
this finding.
Results
Transmission electron microscopy (TEM) shows
interaction of polyomavirus and microtubules
To study the progression of polyomavirus infection in
primary BMK cells, monolayers were infected with the
polyomavirus strain PTA and then harvested at 72 and 96 h
p.i. and processed for TEM as described under Materials
and methods. This procedure allowed several cycles of virus
replication, and a large amount of cells and intracellular
virus particles could be seen. During these studies, obser-
vations were made that suggested a physical interaction
between viral particles and microtubules. As shown in Fig
1, nonenveloped polyomavirus particles were observed in
the cytoplasm closely associated to the free end as well as
along the sides of microtubules. The nature of these micro-
tubules could be confirmed according to their size (25 nm),
structure, and intracellular location and organization (Al-
berts et al., 1994). Although most of the viral particles were
observed associated to the free ends of microtubules, there
were some other particles juxtaposed along the sides of
microtubules. Many viral particles were also seen in the
nuclei and also tightly attached to cell membranes (not
shown).
Colchicine and nocodazole treatment prevents
progression of polyomavirus infection in cell cultures
To investigate the role played by microtubules in the
intracellular migration of polyomavirus, permissive cell cul-
tures were treated with drugs that are known to selectively
inhibit the microtubular network. The progression of the
infection in the absence of functional microtubules was
Fig. 1. Ultrastructure of polyomavirus in infected BMK cells. Nonenveloped, rounded, 45-nm viral particles are clearly observed (arrows) attached to the tip
of 25-nm microtubules (arrowheads) as well as along the sides of microtubules. These structures are located in the cytoplasm of the cell, 96 h p.i. and, since
this is a late infected cell showing nonenveloped particles, presumably these particles are exiting the cell, not entering. Bar  100 nm.
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monitored by the expression of the major viral capsid pro-
tein VP-1 detected by immunofluorescence.
Subconfluent primary baby mouse kidney (BMK) cells
were treated with the antimitotic drug colchicine. This drug
is known to prevent the polymerization of tubulin into
microtubules. Two hours after adding the drug, a marked
disruption of the microtubules was evident by immunoflu-
orescence (not shown). At this time, cells were infected with
the polyomavirus strain PTA. As a control, another group of
cells received no drug treatment (untreated controls) and
was infected under the same conditions with the virus, while
a third group of untreated cells was infected with a mock
lysate. After the viral adsorption had finished, cultures were
thoroughly washed with medium to remove any viral par-
ticles that were not cell bound. Fresh medium containing
colchicine was added immediately to the first cell group
while the control ones received regular media without any
additional drug. Colchicine treatment did not reduce cell
viability significantly according to the classic trypan blue
dye-exclusion test. Several coverslips of the different ex-
perimental groups were fixed either prior to infection or
48 h p.i. Cells were labeled both with an antitubulin anti-
body to show the microtubular network and with the anti-
VP-1 antibody A3 as a viral marker. VP-1 nuclear labeling
of the cells that were infected with polyomavirus but were
not treated with colchicine showed that one in every four
cell was infected with PTA. However, colchicine-treated
cells did not show any nuclear VP-1 in the immunofluores-
cence (Figs. 2A–D).
To strengthen this result, a second set of experiments was
performed but this time a reversible microtubular inhibitor,
nocodazole, was used. BMK cultures were treated with
nocodazole 12 h prior to infection with PTA. Control cells
received no drug treatment and were either infected with
PTA or were mock infected as described above. More than
90% of the cells treated with nocodazole were viable ac-
cording to the trypan blue test. Half of the coverslips were
fixed at 48 h p.i. Then, all the remaining samples were
washed to remove the nocodazole and nocodazole-free me-
dium was added to all the plates. These cultures were
incubated for additional 48 h at 37°C, when coverslips were
processed for indirect immunofluorescence (IF). As shown
in Figs. 2E–H, at 48 h p.i. 25% of the nocodazole-free
PTA-infected cells showed positive nuclear VP-1 labeling
(Fig. 2F), while cells that received the virus and were
treated with nocodazole showed no sign of infection accord-
ing to the VP-1 labeling (Fig 2 G). After removing nocoda-
zole from the culture medium and completing another 48 h
in nocodazole-free medium, the number of VP-1-positive
nuclei was comparable to the untreated group (23%) with-
out any additional input of polyomavirus (Fig 2H). There-
fore, progression of polyomavirus infection is halted by the
disruption of the microtubular network caused by nocoda-
zole but was restored when this microtubular inhibitor was
removed.
BMK cells are primary epithelial cells that polarize in
culture and are permissive for polyomavirus infection. The
virus can also establish a productive infection in NIH 3T3,
which is a continuous cell line of fibroblastic origin. To
prove that polyomavirus infection relays on the integrity of
the microtubular network in both epithelial and nonepithe-
lial cells, experiments similar to the ones described above
were performed but this time using NIH 3T3 cells. Further-
more, a more detailed analysis could be done using this cell
type due to the relative simplicity of working with a con-
tinuous cell line.
NIH 3T3 cultures that were grown on glass coverslips
were treated with colchicine as described for the BMK cells
and then infected with the polyomavirus strain PTA. As a
control, another group of cells received no drug treatment
and was infected under the same conditions, while a third
group of cells was infected with a mock lysate. After a 2 h
adsorption, the monolayers were thoroughly washed with
culture medium to eliminate any remaining extracellular
virus. Fresh medium containing colchicine was added im-
mediately to the first cell group while the control ones
received regular medium without any additional drugs. Sev-
eral coverslips of the different experimental groups were
taken from the dishes at 6, 18, and 48 h p.i. and fixed with
methanol. These cells were processed for IFI as described
above. At the same time, the monolayers were carefully
scraped and the cell pellet was immediately fixed for TEM.
Colchicine-treated NIH 3T3 cells showed a remarkable
disruption of the microtubules, which were replaced by
masses of amorphous fluorescein-positive spots in the cy-
toplasm (Figs. 3D, E, and F). Untreated control cells
showed a clear microtubular network (Figs. 3A, B, and C).
None of the infected cells, whether they were treated with
colchicine or were left untreated, showed any signs of VP-1
labeling shortly after infection at 6 h p.i. (Figs. 3A and D).
At 18 h p.i. some VP-1-positive spots were seen in the
colchicine-untreated cells surrounding the nucleus (Fig. 3B)
and at 48 h p.i. 20% of the untreated infected cells had a
clear nuclear labeling for VP-1, while only 1% of the col-
chicine-treated cells were positive for this viral protein
(Figs. 3C and F). The trypan blue dye-exclusion test con-
firmed that colchicine treatment did not alter cell viability
since more than 98% of the cells were alive. Ultrastructural
analysis revealed the presence of 45 nm nonenveloped
rounded particles in the nuclei after 48 h p.i. in the col-
chicine-free infected control cells, while no particles were
detected in the colchicine-treated infected cells (data not
shown).
As with the BMK cells, NIH 3T3 cells were cultured on
glass coverslips and treated with nocodazole 12 h prior to
infection with PTA. The control group was left untreated
and infected with PTA and another group was mock in-
fected as described above. After a 2 h adsorption, the mono-
layers were thoroughly washed to remove any remaining
extracellular virus. Since it can be argued that not all the
extracellular virus was efficiently removed with this wash
step, a polyclonal serum with known neutralizing effects for
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polyomavirus (A3) was used to eliminate a possible contri-
bution from any remaining extracellular virus. Cells that
were initially treated with nocodazole received fresh me-
dium containing nocodazole together with the A3 antibody.
Control infected cells received regular media with A3 an-
tibody without any additional drug. Half of the coverslips
were fixed at 48 h p.i. At the same time, samples for TEM
were taken and fixed as previously described. Then, all the
Fig. 2. Colchicine inhibits polyomavirus infection in BMK cells. Untreated BMK cells were mock infected (A) or infected with PTA (B). A third group of
cells was treated with colchicine and mock-infected (C) or infected with PTA (D). All samples were fixed and double IFI was performed for VP-1
(rhodamine—nuclear) and tubulin (fluorescein—cytoplasmic). At 48 h p.i., VP-1 is clearly present in the nucleus of colchine-free PTA-infected cells (B).
The microtubular network is absent in colchicine-treated PTA-infected cells (D) which have no sign of nuclear VP-1 labeling as well as in the
colchicine-treated, mock-infected cells (C). Nocodazole prevents progression of polyomavirus infection in BMK cells. Untreated BMK cells were mock
infected (E) or infected with PTA (F). Another group of cells were kept in DMEM plus 2 M nocodadazole for 12 h and then infected with PTA (G). Double
IFI was performed for VP-1 (nuclear) and tubulin (cytoplasmic). After 48 h p.i., nocodazole-treated cells show no VP-1 in the nuclei (G) and an altered
microtubule network. At this time, nocodazole-free PTA-infected cells show VP-1 intranuclear labeling (F). Forty-eight hours after nocodazole removal from
the cultures, cells show a VP-1-positive nuclei (H) similar to the pattern present in untreated cells (F).
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remaining cell cultures were thoroughly washed to remove
the nocodazole and nocodazole-free medium was added to
all the plates. In all cases, cells were refed with fresh
medium plus A3 antibody. These cultures were incubated
for additional 48 h when samples were processed for IFI and
monolayers were fixed and embedded for TEM. Results
showed that at 48 h p.i. cells treated with nocodazole had
lost the network pattern of microtubules but, in this case, the
microtubules organization centers (MTOCs) were con-
served (Fig. 4B). At the same time point, 18% of the
untreated infected control cells showed VP-1-positive nu-
clei (Fig. 4E), while only 1% of the drug-treated infected
ones showed signs of viral infection. Moreover, after the
nocodazole-treated cells were maintained in drug-free me-
dium for an additional 48 h, 10% of the nuclei became
positive for VP-1 (Fig. 4C). Cell viability was higher than 98%
as measured by trypan blue staining. Simultaneously, in sam-
ples that were studied by TEM, which showed that viral par-
ticles were present in the nucleus of infected nocodazole-free
cells at 48 h p.i., viruses were not detected in the infected
nocodazole-treated cultures. When nocodazole was removed
from the cell cultures for an additional 48 h, abundant viral
particles were observed in the nucleus and in the cytoplasm
tightly attached to the cell endomembranes in a similar pattern
as the one present in the control infected cells (not shown).
Colchicine or nocodazole do not impair cell endocytosis
It has been well established that the major effects of
drugs such as nocodazole and colchicine are related to the
Fig. 3. Colchicine inhibits polyomavirus infection in NIH 3T3 cells. Untreated NIH 3T3 cells (A, B, and C) or cells treated with colchicine (D, E, and F)
were infected with polyomavirus PTA strain and double IFI was performed for VP-1 (rhodamine) and tubulin (fluorescein). Six hours post infection, VP-1
is absent in both untreated (A) and treated cells (D). After 18 h p.i., VP-1 could be detected in the cytoplasm surrounding the nucleus of colchicine-free
PTA-infected cells (B) but was absent in colchine-treated PTA-infected cells (E). At 48 h p.i., VP-1 is present in the nucleus of infected control cells (C)
but is absent in colchicine-treated PTA-infected ones (F). Colcichine treatment (D, E, and F) completely disrupts the microtubules.
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disruption of the microtubular network caused by these
drugs. The lack of progression observed in polyomavirus
infection when cells were treated with colchicine or nocoda-
zole was probably due to the absence of functional micro-
tubules and not to other effects that these drugs might have
over the cell internalization mechanisms. To confirm this,
the integrity of the cell uptake mechanisms was studied
using a standard Lucifer yellow (LY) test, which is a routine
test to evaluate the integrity of the cellular endocytic path-
ways. NIH 3T3 cell cultures were treated with colchicine or
nocodazole as described before. After 2 h of colchicine
treatment and 12 h of nocodazole treatment, culture media
were replaced by fresh media containing inactivated LY.
Cells were incubated for one additional hour and then were
washed to remove extracellular LY. At this point they were
fixed with standard techniques. Samples were observed with
an epifluorescence microscope. All the samples showed a
similar Lucifer yellow endosomal pattern whether they were
treated with colchicine or nocodazole or were left untreated.
This pattern showed the distribution of internalized LY as
rounded, fluorescent dots in the cytoplasm (endodomes) in
nocodazol or colchicine-treated cells as well as in the un-
treated cultures (not shown). This result indicated that the
cell endocytic pathways remained functional in the presence
of colchicine or nocodazole.
Nocodazole treatment inhibits the release of polyomavirus
from infected cells
The experiments described above demonstrated that the
indemnity of microtubules is critical for polyoma virus
transport to the cell nucleus and that the cell culture treat-
ment with colchicine or nocodazole does not impair cell
endocytosis. To study if the microtubular network is also
essential for the virus to leave the cell after a productive
infection, we checked the release of polyoma virus into the
Fig. 4. Nocodazole prevents progression of polyomavirus infection in NIH 3T3 cells. NIH 3T3 cells were treated with nocodazole (B, C) or left untreated
(E, F) and then infected with polyomavirus PTA. Double IFI was performed for VP-1 (rhodamine  red) and tubulin (fluorescein  green). After 48 h p.i.,
nocodazole-treated PTA-infected cells show no VP-1 in the nuclei (B) and an altered microtubule network that maintains the MTOCs. Nocodazole-free
PTA-infected cells show VP-1 intranuclear at 48 and 96 h p.i. (E and F). Forty-eight hours after nocodazole removal from the cultures (96 h p.i.), cells show
VP-1 positive nuclei (C). The syncytial arrangement is a consequence of mitosis in the presence of nocodazole. A and D show nocodazole-free uninfected
control NIH 3T3 cells.
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culture media of infected cells, either treated with nocoda-
zole or after this drug was removed. NIH 3T3 cells were
cultured as described above until they had reached 60–70%
confluency. At that point, five sets of cells were treated as
follows: one set was mock-infected; the second set was
infected with the polyoma virus strain PTA; the third set
was infected with PTA during 24 h; and then nocodazole
was added and maintained until the end of the experiment;
the fourth set was treated with nocodazole 12 h before viral
infection and nocodazole was maintained in the culture
medium during all the experiment; and the fifth set of cells
was also treated with nocodazol 12 h before viral infection,
nocodazole was maintained during 24 h p.i., but then it was
removed and fresh medium was added. Conditions for viral
adsorption, m.o.i., and cell cultures were identical as before.
At 0, 24, and 72 h p.i., 1 ml of culture media from each one
of the four sets of cell cultures was taken and maintained at
70°C until all samples were collected. In every time point,
1 ml of fresh medium was added to each one of the cell
cultures. Then, NIH 3T3 cells were cultured onto glass
coverslips placed into 60-mm plastic petri dishes as previ-
ously described and adsorbed with 0.3 ml of each one of the
samples previously taken at every time point. After 2 h of
adsorption, the inocula were removed and 5 ml of DMEM
containing 5% fetal calf serum was added to each petri dish.
Cells were incubated at 37°C with 5% CO2 24 h, and then
coverslips were fixed in methanol. VP-1 was detected by IFI
as previously described and the percentage of infected cells
was established in each sample.
The data in Fig. 5 indicate that when cells were infected
and then incubated with nocodazol they only released very
few infectious virus particles into the culture media. How-
ever, when nocodazole was removed after 24 h p.i., the viral
progeny was released from the infected cells into the culture
media.
Polyomavirus major capsid protein VP-1
coimmunoprecipitates with tubulin
The series of results described above suggested that
polyomavirus might interact with the microtubular protein
tubulin. To test this possibility, coimmunoprecipitation ex-
periments were designed using an antitubulin monoclonal
antibody followed by Western blot. Protein extracts were
prepared from NIH 3T3 and BMK cells previously infected
with PTA for 48 h. Mock-infected lysates were used as
controls. Samples were resolved in SDS–acrylamide gels
and transferred onto PVDF membranes. Westerns were per-
formed using antitubulin or anti-VP-1 antibodies. In three
independent experiments, tubulin coimmunoprecipitated
with the major capsid protein VP-1 in both BMK and NIH
3T3 extracts. In another set of experiments, coimmunopre-
cipitation of tubulin and VP-1 was observed in BMK-in-
fected cells at 72 and 96 h p.i. Addition of sepharose beads
alone or preimmune serum to the extracts failed to immu-
noprecipitate any of the proteins (Fig. 6).
Actin microfilaments depolymerization has no effect in
polyomavirus infection
The possibility that the actin fibers might be of impor-
tance in polyomavirus infection was studied using cytocha-
lasin D, which prevents polymerization of the actin micro-
filaments. NIH 3T3 and BMK cell cultures were treated
with cytochalasin D 3 h before infection with PTA or mock
infected, while control cells were infected with PTA without
previous treatment with cytochalasin D. Samples were
taken at 48 h p.i. and fixed using standard techniques. The
pattern of viral infection was the same in both cell groups:
about 25% of the cells were positive for VP-1 whether they
had been treated with cytochalasin D or had been left
Fig. 5. Nocodazole prevents the passage of polyomavirus from the cell to the culture medium. NIH 3T3 cells were mock-infected (A), infected with PTA
(B), infected with PTA during 24 h, and then treated with nocodazole and maintained with this drug during all the experiment (C), treated with nocodazole
from 12 h before the infection with polyomavirus and nocodazole maintained during the whole experiment (D), and treated with nocodazole, infected with
PTA, and then washed and fresh medium added (E). Samples of supernatants were taken at 0, 24, and 72 h p.i. and polyoma was titrated by adsorption onto
NIH 3T3 cells grown on glass coverslips. Virus production is expressed as the percentage of VP-1 positive cells detected by IFI. It is clear that while
nocodazole is present in the medium the release of polyomavirus from the cells is minimal, while it is remarkably increased after nocodazole was removed.
It is also remarkable that the treatment with nocodazole of cells previously infected with PTA inhibits the virus release.
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untreated (Fig. 7). IFI using a monoclonal antibody antiactin
revealed that the microfilaments were remarkably altered in
cells treated with cytochalasin D. These data showed that
the role played by actin microfilaments, if any, is not crucial
for viral migration.
Discussion
Although it has been well established that viral intracel-
lular migration plays a central role in viral pathogenesis, the
mechanisms used by nonenveloped viruses to move through
the host cell cytoplasm remain obscure. We have studied the
role of microtubules and actin fibers in the intracellular
traffic of murine polyomavirus in primary polarized epithe-
lial cells and in a continuous fibroblastic cell line. Our
results demonstrated that an intact microtubular network is
essential for the progression of polyomavirus infection since
the virus could not reach the nucleus in cells treated with
colchicine or nocodazole. The drug nocodazole is a revers-
ible inhibitor of the microtubules that allowed us to analyze
the progression of the infection once the drug was removed
and the microtubular network was restored. The experi-
ments showed that after nocodazole was removed, infection
could progress. Where did the virus that established the
infection after nocodazole was removed come from? Since
no additional virus was added to the cells after the drug was
removed and any possible contribution from extracellular
virus was minimized by washing and by the addition of a
neutralizing antibody to the media, progression of the in-
fection was due to the initial input of virus many hours
before. In nocodazole-treated cultures, polyomavirus did
enter the cells and probably stayed in the periphery of the
cytoplasm given that we have demonstrated that none of the
drugs used affected the cell uptake mechanisms. Most
likely, after nocodazole was removed, microtubules repoly-
merized allowing the virus to interact preferentially with the
microtubular free ends and with their lateral sides, and in
that way the virus could reach the nucleus. While the TEM
studies confirmed the lack of viral infection when microtu-
bules were disrupted, it also provided strong evidence for a
physical association between the virus and the microtubular
network. In this regard, BMK cell cultures infected at 72–96
h p.i. showed nonenveloped polyomavirus particles attached
to the free end of microtubules. The nature of microtubules
can be assumed according to their structure, shape, and
cytoplasm localization. Multiple naked polyomavirus parti-
cles were observed in the free ends of microtubules located
in different parts of the cytoplasm, some of them near the
plasma membrane. Some classic articles have described that
Fig. 6. Coimmunoprecipitation of VP-1 and tubulin. BMK cells were infected with PTA or mock infected, then harvested at 72 and 96 h p.i. Protein extracts
obtained from these cells were used for immunoprecipitation using an antitubulin antibody. Proteins were resolved in SDS–12% PAGE gels followed by
Western blot. Two gels were run simultaneously and in parallel and the same samples were loaded in both of them. In one of the gels tubulin was detected
using a mouse immunoglobulin antitubulin (A). In the other gel, detection of VP-1 was done using a rabbit immunoglobulin anti-VP-1 (B). The secondary
antibodies were goat serum anti-rabbit immunoglobulins or goat serum anti-mouse immunoglobulins, both conjugated with 125I. (A) 1: Mock-infected cells
immunoprecipitated with antitubulin serum; 2: infected cells immunoprecipitated with mouse preimmune serum; 3 and 4: infected cells immunoprecipitated
with antitubulin serum; 5: Sepharose beads alone. (B) 1: Mock-infected cells immunoprecipitated with antitubulin serum; 2: infected cells immunoprecipitated
with mouse preimmune serum; 3 and 4: infected cells immunoprecipitated with antitubulin mouse immunoglobulins; 5: Sepharose beads alone; 6:
polyomavirus-infected cell culture without immunoprecipitation, used as a positive control. In (A) immunoprecipitation of tubulin (55-kDa bands) can be
observed only when specific antitubulin serum was used. There is no tubulin in the cell extract treated with preimmune serum or with beads alone. In (B)
VP-1 (45 KDa) can be observed only in the extracts of polyomavirus-infected cells immunoprecipitated with antitubulin serum. Thus, coimmunoprecipitation
of both proteins is evident.
Fig. 7. Cytochalasin D does not impair polyomavirus infection. NIH 3T3
(A) and BMK (B) cells were left untreated or were kept in DMEM plus 2
mM cytochalasin D for 2 h. Cells were infected with polyomavirus PTA
strain or with a mock lysate. At 48 h p.i. viral VP-1 and cellular actin was
detected using double immunofluorescence. The graphic represents the
percentage of PTA infected cells according to VP-1 nuclear labeling.
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polyomavirus can be seen not only as 45-nm spherical
structures but also as filaments. Thus, it could be argued that
what we described as microtubules could have been fila-
mentous forms of polyomavirus. We have indeed observed
these images in the same cell cultures where the association
between polyomavirus and microtubules was seen, but they
can be easily distinguished from microtubules in that the
former is located only in the nuclei, has an average shape of
45 nm and does not have the ultrastructural appearance of
microtubules (not shown). Moreover, a detailed observation
of the association between polyomavirus and microtubules
showed a naked polyomavirus particle, then a narrow
“neck”, and then a structure with all the characteristic of a
microtubule. We have also found polyomavirus particles
surrounded by a trilaminar structure that resembled mem-
branes as other authors have described (Richterova et al.,
2001), but these structures were mostly associated with
plasma membranes or were free in the cytoplasm. While
most viral particles were associated with the free end of
microtubules, some others were seen juxtaposed along the
sides of microtubules. This last finding suggests the possi-
bility that the interaction of polyomavirus with microtubules
could also be mediated by the interaction with microtu-
bules-associated motor proteins such as kinesins and dy-
nein, located along the microtubule. To explain the presence
of viral particles not associated with microtubules, two facts
have to be taken into consideration. One is that it should not
be necessary that all polyomavirus particles located at a
certain moment in the cytoplasm of a cell infected after 72 h
have to be associated with microtubules and migrate toward
the nucleus or to the plasma membrane all together. The
other is that an electron micrograph is a two-dimensional
image of a fact that happens in a three-dimensional way.
Thus, it is quite possible that the particles apparently not
associated with microtubules shown in Fig 1 are indeed
associated with them, but these microtubules had not been
cut by the knife in the same sense as the viral particles.
Coimmunoprecipitation of tubulin and the viral major
capsid protein VP-1 further confirmed the interaction be-
tween tubulin and the virus when an antitubulin serum was
used. Unfortunately, we could not strengthen this result with
the reciprocal reaction since none of the available anti-VP1
antibodies we have tried were successful in immunoprecipi-
tating VP-1. Nevertheless, the images observed by TEM
where polyomavirus particles are attached to microtubules,
the experiments performed with drugs that selectively de-
polymerize microtubules and the coimmunoprecipitation of
tubulin and VP-1 when an antitubulin serum was used,
provided strong evidence that this association actually oc-
curs. Moreover, coimmunoprecipitation of tubulin and VP-1
was observed in BMK cells extracts at 72 and 96 h p.i.,
when infectious virus release was detected in the superna-
tants of cells in the absence of nocodazole and when viral
particles were observed associated with microtubules.
Taken together, these data reinforce the hypothesis of the
dependence on microtubules for virus exit.
This work demonstrated that microtubule disruption in-
hibits polyomavirus migration from the cell membrane to
the nucleus and rules out the contribution of actin fibers in
polyomavirus intracellular movement. Moreover, we were
able to show that the indemnity of the microtubular network
is also essential for polyomavirus to leave the cell after
infection. In this regard, the results presented here establish
that cells treated with nocodazole from 12 h before the
infection with polyomavirus until the end of the experiment,
72 h later, released very few infectious virus into the culture
media, while cell cultures where nocodazole was removed
24 h after the infection did allowed a massive passage of
infectious virus to the culture media almost with the same
titers observed in the cells used as a control (only infected
with poliomavirus without nocodazole). However, it could
be argued that this result was due to inhibition of early
stages of infection by nocodazole. To clearly demonstrate
that the indemnity of microtubules is necessary for virus
release, in another experiment the infection of the cell cul-
tures was done 24 h before nocodazole was added, thus
allowing polyomavirus to enter the cell in the absence of
any drug, and then cells were treated with nocodazole as
described above. As shown in Fig. 5, very few infectious
virus were detected in the supernatant of cell cultures in-
fected with polyomavirus and then treated with nocodazole,
while a large amount of infectious virus could be recovered
in the supernatant of polyomavirus-infected, nocodazol-un-
treated cells. This difference can only be explained by the
absence or presence, respectively, of polymerized microtu-
bules. The results presented in this work (in contrast to other
studies concentrating on the early stages of infection) fo-
cused on both the early and the later stages of polyomavirus
infection, including the exit of progeny virus, and demon-
strate that the indemnity of the microtubular network is
necessary for virus entrance to the cell and for virus release
from the cell. This last point is provocative, since it pro-
poses that polyomavirus leaves the infected cell using mi-
crotubules and not just as a consequence of cell lysis, as has
been described in other nonenveloped viruses.
Polyomavirus transport is probably dependent on the
interaction between the virus major capsid protein VP-1 and
tubulin. A novel mechanism for polyomavirus intracellular
traffic that implies a physical association between viral
nonenveloped particles with the free end of microtubules is
proposed, although the characterization of the molecular
bases of this interaction is beyond the scope of this article.
Another aspect that deserves further study is how virus
actually travels using microtubules. Some of the already
known microtubular motor proteins (MAPs) such as dynein
and kinesins are likely to mediate microtubular-dependent
viral transport (Alonso et al., 2001). The possibility that the
association to alternative MAPs might promote movement
is suggested in this work by the ultrastructural observation
of some polyomavirus particles attached to the sides of
microtubules. The possible association between MAPs and
polyomavirus in currently under investigation.
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Materials and methods
Virus
The polyomavirus PTA strain used was a kind gift of
Thomas L. Benjamin (Harvard Medical School, Boston,
MA). Viral stocks were produced by infecting primary baby
mouse kidney cells prepared from specific pathogen-free
BALB/c mice. Cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) (Gibco) and 10% calf serum
(CS) (Gibco), and then infected at a multiplicity of infection
of 0.1 PFU per cell and incubated at 37°C in a 5% CO2
atmosphere until complete cytopathic effect was observed.
Cultures were harvested with a rubber policeman and son-
icated three times, and cell debris was removed by centrif-
ugation for 15 min at 400 g. The titers of the supernatants
were determined on NIH 3T3 cells under agar (Turler and
Beard, 1985) and then aliquoted and stored at 20°C.
Animals
BALB/c mice were obtained from the University of La
Plata School of Veterinary Medicine, La Plata, Argentina
and bred in pathogen-free conditions. Mice were kept five to
a box and fed on pellets ad libitum.
Cell cultures
BMK cells were prepared from the kidneys of 8- to
10-day-old BALB/c mice. Kidneys were dissected under
sterile conditions, cut into 1 mm pieces, and kept in
DMEM–0.05 mM EDTA. After washing the kidney sec-
tions in DMEM–EDTA, the tissue suspension was incu-
bated in DMEM–0.25 M trypsin at 37°C with continuous
agitation. After 10 min the cell suspension was removed,
leaving the larger tissue pieces behind. This procedure was
repeated three times to allow for almost complete disaggre-
gation of the tissue sections. Cells were then washed with
fresh DMEM and 10% CS, pelleted at low speed, washed
again, and pelleted in PBS. The procedure described by
Vinay et al. (1981) for preparation of tubule fragments by
Percoll centrifugation was followed with some modifica-
tions. The cell pellet was resuspended in a 50% isotonic
Percoll mixture made from concentrated HEPES solution
(136 mM NaCl, 9.4 mM KCl, 2.50 mM CaCl2, 2.50 mM
MgSO4, 2.36 mM KH2PO4, 20 mM glucose, 40 mM Na
cyclamate, 10 mM HEPES pH 7.40) and Percoll (Pharma-
cia). The F1 band was removed from the gradient and
washed three times in DMEM–10% CS. Cells were then
resuspended in DMEM–10% CS and passed through a sieve
to minimize glomeruli contamination. The cell suspension
was seeded in plastic tissue culture dishes with or without
glass coverslips with DMEM–10% CS plus antibiotics (pen-
icillin/streptomycin) and incubated at 37°C for 72 h to allow
cell polarization before they were ready to use in the dif-
ferent experimental procedures.
NIH 3T3 cells were cultured on coverslips placed in
plastic tissue culture plates with DMEM–10% CS. Cultures
were incubated at 37°C in a 5% CO2 atmosphere and used
when they reached 75% confluency.
Infection and drug treatments
Cells were infected using the polyomavirus PTA strain
stocks (see above) at a multiplicity of infection of 0.2 PFU
per cell. Viral adsorption was carried out for 2 h at 37°C in
minimal volume. After adsorption, cells were washed twice
with medium and fresh medium plus serum was replaced.
When appropriate, cells were treated for 2 h before infection
in normal medium containing 50 M colchicine (from 20
mM stock in DMSO) (Sigma) or 1 M cytochalasin D
(from 10 mM stock in DMSO) (Sigma). Cells were main-
tained in these drugs during the entire length of the exper-
iment. In experiments where nocodazole (Sigma) was used,
cells were incubated with this drug for 12 h prior to infec-
tion at a concentration of 2 M (from 20 mM stock in
DMSO) and maintained in this drug for the first 48 h p.i. A
rabbit antipolyomavirus major capsid protein VP-1 with
viral neutralizing activity was added to the medium at a
dilution of 1:10,000. This serum called A3 was a gift of
Thomas L. Benjamin (Harvard Medical School). Then
monolayers were washed three times to remove the nocoda-
zole, and fresh medium containing 10% CS was added.
Indirect immunofluorescence
Cells were grown on coverslips and fixed for 20 min in
methanol and then washed with PBS and blocked with 5%
normal goat serum in PBS. Cells were subjected to double
immunofluorescent labeling using the A3 serum at 1:1000
dilution in PBS together with a monoclonal anti--tubulin
antibody (Sigma) at a 1:500 dilution in PBS. After washing
thoroughly with PBS, a goat anti-rabbit immunoglobulin
conjugate with rhodamine (Sigma) was added at a dilution
of 1:500 together with a goat anti-mouse immunoglobulin
conjugated with fluorescein (Sigma) at a 1:500 dilution in
PBS. After incubating cells for 1 h in the presence of the
secondary antibodies, samples were washed with PBS and
mounted onto glass slides with a mix of 50% glycerol/50%
PBS. Slides were observed in a Zeiss immunofluorescence
microscope with epiillumination. In every experiment, 500
cells per slide were counted.
To label the actin microfilaments (Spector et al., 1998),
cell cultures grown as described above were fixed with 4%
formaldehyde solution in PBS at room temperature for 20
min. Cells were then washed with 0.5 M glycine in PBS
followed by permeabilization with a 30-s extraction with
cold acetone. After three washes with PBS, cells were
blocked as described above. Samples were subjected to
double labeling using the A3 serum and a monoclonal
antiactin antibody (Sigma) at a 1:200 dilution in PBS. In-
cubation was carried out overnight at 4°C. The incubation
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with the secondary antibodies was identical to the one
described before. Coverslips were mounted and processed
as above.
Lucifer yellow uptake
Lucifer yellow (dilithium salt, Sigma) was inactivated as
described by Bomsel et al. (1989) and was added at a
concentration of 10 mg/ml to serum-free medium. BMK
cells grown on coverslips were incubated with inactivated
LY for 60 min. Then the cells were washed three times with
PBS and fixed in cold methanol (4°C) for 10 min. Cover-
slips were mounted on glass slides and analyzed using an
epifluorescent microscope with a fluorescein filter. The
same test was performed with NIH 3T3 cells.
Transmission electron microscopy
Cell monolayers were fixed in 4% formaldehyde freshly
prepared from paraformaldehyde plus 1% glutaraldehyde in
PBS, pH 7.4, 1 h at room temperature, and then harvested
with a rubber policeman and centrifuged at 100 g for 5 min.
After postfixation in 1% osmium tetroxide, cell pellets were
routinely embedded in Vestopal. Slides were obtained using
glass knives, and grids were stained with uranyl acetate and
lead citrate. Specimens were observed in a Zeiss EM 109-T
transmission electron microscope, at 80 kV.
Immunoprecipitation and western blotting
Protein extracts were prepared from cell monolayers by
washing cells twice with PBS. Cells were scraped and
pelleted, followed by the addition of a cold lysis buffer (50
mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA, 1 mM DTT,
1% NP-40) and by sonicating for 30 s. Extracts were cleared
by centrifugation at 400 g at 4°C for 10 min.
For the immunoprecipitations, protein extracts and the
appropriate antibody were incubated on ice for 1 h followed
by the addition for 1 h of protein A–Sepharose (Sigma)
previously washed three times in lysis buffer. The immu-
noconjugates were recovered by spinning and washing three
times with lysis buffer. Pellets were resuspended in
Laemmli sample buffer and heated at 90°C for 2 min. After
cooling samples on ice for 5 min, immunoprecipitations
were resolved in sodium dodecyl sulfate (SDS)–acrylamide
gels. Gels were blotted onto PVDF membrane (Hy-bond
Pharmacia) and incubated with TNET buffer (10 mM Tris,
3 mM EDTA, 50 mM NaCl, 1% Tween 20, pH 7.5) con-
taining 5% nonfat dry milk. For Westerns, the A3 serum
was diluted 1:10,000 and the antitubulin antibody was di-
luted 1:5000 and incubated for 1 h, followed by goat anti-
rabbit immunoglobulins conjugated with 125I (NEN,
1:10,000) or goat anti-mouse immunoglobulin conjugated
with 125I (NEN, 1:10,000). Extensive washing was per-
formed after each incubation using TNET. Blots were de-
veloped using Kodak XAR film.
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